胶囊内镜在小肠疾病诊断中的作用

目的:小肠疾病很难诊断,现有的诊断技术又不尽如人意,而胶囊内镜能发现整个小肠内的微小病变。为此,我们对胶囊内镜在小肠疾病诊断中的价值进行评估。方法:自2002年5月至2003年9月,我们对经结肠镜、胃镜、X线钡餐造影、小肠钡灌造影、血管造影或核素扫描等检查未发现异常的79例疑患小肠疾病、尤其是不明原因消化道出血的患者,进行胶囊内镜检查,其中不明原因的消化道出血患者56例。结果:75例完成最终研究。75例患者中经胶囊内镜检查共发现异常63例,检出率为84％;其中能明确解释临床病因者50例,诊断率为66.6％,包括消化道血管病变21例、小肠炎症性肠病16例、小肠息肉5例、小肠恶性间质肿瘤2例、小肠类癌1例(该患者同时伴升结肠脂肪瘤)、淋巴瘤1例、粘膜下肿瘤3例及憩室1例。所获取的图像质量良好。结论:胶囊内镜对小肠疾病尤其是不明原因消化道出血具有良好的诊断价值。     

胶囊内镜的临床应用

目的 小肠疾病很难诊断，现有的诊断技术又不尽如人意，而胶囊内镜（M2A）能发现整个小肠内的微小病变，且为非侵入性，患者无需住院，因此，对胶囊内镜在小肠疾病诊断中的价值。依从性和安全性进行评估。方法 自2002年5月至9月，我们对经结肠镜，胃镜，X线钡餐造影，小肠钡灌造影，血管造影或核素扫描等检查未发现异常的15例疑患小肠疾病的患者，进行胶囊内镜检查，其中不明原因的消化道出血12例。结果 15例中发现病灶11例（73.3%)，包括血管发育不良，Dieulafoy病，毛细血管扩张征，静脉扩张，息肉样病变，黏膜下肿瘤，脂肪瘤，口疮样小溃疡（Aphthous ulcer)，克罗恩病类癌及出血性胃炎等，其中4例患者同时存在2种病灶，所获取的图像质量良好，胶囊停留于胃内的平均时间为82min(6-311min)，小肠内平均运行时间为248min(104-396min)，平均到达盲肠时间为336min(180-470min)，平均记录时间为449min(300-510min)，医师对胶囊内镜所传输图像的平均读片时间为82min(30-120min)，平均获取照片数为57919张，胶囊平均排出体外时间为33h(24-48h)，整个操作过程患者耐受性甚佳，无任何痛苦，吞咽胶囊无任何困难，检测过程中无任何并发症发生。结论 胶囊内镜是对小肠疾病具有诊断价值的医疗设备，其安全性高，依从性好。     

小肠胶囊内镜的临床应用价值

小肠曾因其特殊的解剖位置而成为消化系统的检查盲区,自第一个批准用于临床的胶囊内镜上市以来,其简便、安全、无创的特点使小肠胶囊内镜被公认为目前诊断小肠疾病的一线工具,用于诊断不明原因消化道出血、缺铁性贫血、小肠肿瘤、克罗恩病等小肠疾病。文章就小肠胶囊内镜在小肠疾病诊断的临床应用及研究进展做一阐述。     

胶囊内镜的临床使用价值

小肠是消化道最长的器官,各种小肠疾病目前越来越被人们认识,而既往传统的各种检查方法敏感性和准确性都较低,很难在术前作出明确诊断.胶囊内镜是一种无创、可靠、操作简便的内镜.他能对小肠进行全程实景观察,使小肠不再是内镜检查的盲区.     

胶囊内镜诊断小肠血管发育不良40例

在不明原因小肠出血中，小肠血管发育不良较为多见，但其在过去常规X线和同镜检查中难心发现，应用血管造影术、核素扫描、小肠镜后，其诊断率才得到了一定提高。南京市鼓楼医院于2003年2月应用GIVEN公司产的M2A胶囊内镜，在30个月内对86例小肠出血患者实施胶囊内镜检查，共检出小肠血管发育不良40例。     

胶囊内镜与双气囊内镜诊断小肠疾病的比较

目的比较胶囊内镜和双气囊内镜对小肠疾病的检出率和诊断准确性，探讨其联合应用的临床意义。方法对116例不明原因消化道出血和102例不明原因腹痛或腹泻患者，共218例进行内镜检查。其中165例首选胶囊内镜，53例首选双气囊内镜。对胶囊内镜检查阴性或可疑病变者建议双气囊内镜检查，反之亦然。比较两种检查方法对小肠疾病的检出率、诊断率以及患者依从性、不良反应发生率等。结果1例胶囊内镜和2例双气囊内镜操作失败。51例患者行64次双气囊内镜检查，其中34例经口、4例经肛检查，13例分别接受经口和经肛检查。胶囊内镜对小肠病变的总检出率及对不明原因消化道出血的小肠疾病检出率（72．0％和88．0％），均明显高于双气囊内镜（41．2％和60．0％），诊断率也高于后者（51．8％和39．2％）。5例胶囊内镜检查阴性再经双气囊内镜检查者中，1例发现病灶；15例胶囊内镜检查怀疑小肠病变者中，12例经双气囊内镜结合活检病理确诊。而3例双气囊内镜未发现异常者再经胶囊内镜检查发现小肠病变。所有患者均未发生严重不良反应。结论胶囊内镜对小肠疾病检出率高，可作为怀疑小肠疾病，尤其是不明原因消化道出血的首选检查方法；双气囊内镜在胶囊内镜检查阴性者中仍可发现部分病灶，并能明确多数胶囊内镜下可疑病变，可作为胶囊内镜检查后的补充检测手段。     

胶囊内镜在小肠疾病诊断中的作用

目的：小肠疾病很难诊断，现有的诊断技术又不尽如人意，而胶囊内镜能发现整个小肠内的微小病变。为此，我们对胶囊内镜在小肠疾病诊断中的价值进行评估。方法：自2002年5月至2003年9月，我们对经结肠镜、胃镜、X线钡餐造影、小肠钡灌造影、血管造影或核素扫描等检查未发现异常的79例疑患小肠疾病、尤其是不明原因消化道出血的患，进行胶囊内镜检查，其中不明原因的消化道出血患56例。结果：75例完成最终研究。75例患中经胶囊内镜检查共发现异常63例，检出率为84％；其中能明确解释临床病因50例，诊断率为66．6％，包括消化道血管病变21例、小肠炎症性肠病16例、小肠息肉5例、小肠恶性间质肿瘤2例、小肠类癌1例(该患同时伴升结肠脂肪瘤)、淋巴瘤1例、粘膜下肿瘤3例及憩室1例。所获取的图像质量良好。结论：胶囊内镜对小肠疾病尤其是不明原因消化道出血具有良好的诊断价值。     

胶囊内镜下肝硬化患者小肠影像学改变

目的：探讨肝硬化患者小肠黏膜的异常改变。方法：应用OMOM胶囊内镜观察50例肝硬化患者和53位非肝病患者及健康体检人群的小肠影像改变并进行比对。结果：肝硬化患者较非肝病患者及健康体检人群的小肠患溃疡、糜烂、黏膜下血管扩张扭曲发生率高,差异有显著性意义（ P＜0.05）。结论：肝硬化患者的小肠内大量细菌繁殖和血供异常是导致小肠病变的主要原因。     

胶囊内镜诊断不明原因小肠出血15例临床观察

小肠不明原因出血是一个反复发作、慢性的过程。传统的检查方法主要是胃结肠镜检查,由于其无法到达小肠,不能发现小肠部位的病变,阳性检出率较低。随着胶囊内镜的推广使用,小肠部位阳性病变检出率明显提高。2010年4月～2011年7月,我院对15例小肠不明原因出血的患者采用胶囊内镜检查。现报告如下。     

OMOM胶囊内镜对小肠出血的诊断价值

[目的]通过分析不明原因消化道出血(OGIB)疾病患者经OMOM胶囊内镜的检查结果,探討OMOM胶囊内镜对OGIB的診断价值。[方法]收集2009年5月～2011年3月恩施州中心医院27例OGIB患者经OMOM胶囊内镜检查的临床资料,回顾性分析下载到计算机中的图像资料。[结果]未见异常7例,血管显露10例,小肠间质瘤5例,小肠息肉4例,小肠憩室1例,OGIB患者的阳性检出率为74.07%。[结论]OMOM胶囊内镜对于OGIB患者可作为首选的一线检查手段。     

Outcome in obscure gastrointestinal bleeding after capsule endoscopy

AIM: To investigate the clinical impact of capsule endoscopy (CE) after an obscure gastrointestinal bleeding (OGIB) episode, focusing on diagnostic work-up, follow-up and predictive factors of rebleeding.METHODS: Patients who were referred to Hospital del Mar (Barcelona, Spain) between 2007 and 2009 for OGIB who underwent a CE were retrospectively analyzed. Demographic data, current treatment with non-steroid anti-inflammtory drugs or anticoagulant drugs, hemoglobin levels, transfusion requirements, previous diagnostic tests for the bleeding episode, as well as CE findings (significant or non-significant), work-up and patient outcomes were analyzed from electronic charts. Variables were compared by χ² analysis and Student t test. Risk factors of rebleeding were assessed by Log-rank test, Kaplan-Meier curves and Cox regression model.RESULTS: There were 105 patients [45.7% women, median age of 72 years old (interquartile range 56-79)] and a median follow-up of 326 d (interquartile range 123-641) included in this study. The overall diagnostic yield of CE was 58.1% (55.2% and 63.2%, for patients with occult OGIB and overt OGIB, respectively). In 73 patients (69.5%), OGIB was resolved. Multivariate analysis showed that hemoglobin levels lower than 8 g/dL at diagnosis [hazard ratios (HR) = 2.7, 95%CI: 1.9-6.3], patients aged 70 years and above (HR = 2.1, 95%CI: 1.2-6.1) and significant findings in CE (HR = 2.4, 95%CI: 1.1-5.8) were independent predictors of rebleeding.CONCLUSION: One third of the patients presented with rebleeding after CE; risk factors were hemoglobin levels < 8 g/dL, age ≥ 70 years or the presence of significant lesions.     

影响胶囊内镜诊断不明原因消化道出血因素的分析

目的为提高胶囊内镜诊断不明原因消化道出血的诊断率,探讨影响胶囊内镜诊断不明原因消化道诊断率的因素。方法胶囊内镜检查172例,其中不明原因的消化道出血的患者61例,分为2组,A组为胶囊内镜检查明确出血病变者,B组为无明确出血病变者,根据年龄、性别、病史、病变程度、病变表现、排空时间、肠道清洁、检出率、诊断率等对比分析。结果消化道出血的检出率为88．52％,包括胃炎、肠炎、血管畸形、肠息肉、食管静脉曲张等。出血的诊断率为67．2％,包括小肠糜烂,克罗恩病、糜烂性胃炎、溃疡病、肿瘤等。两组病人年龄、性别比较无明显差异,A组病史活动性出血者多,病史长,合并症多,小肠转运时间较长,肠道清洁好,病变程度重,病变检出率高。结论注意病人的选择、合理的小肠转运时间、肠道清洁好、了解出血原因和排序、提高病变鉴别、图像解读及临床综合判断和随访等,可以提高胶囊内镜检查的诊断率,使不明原因消化道出血病变得到及时明确的处理。     

胶囊内镜诊断不明原因消化道出血107例

目的:探讨胶囊内镜在不明原因消化道出血中的诊断价值及其与双气囊小肠镜在病因诊断中联合应用的意义。方法:采用M2A胶囊内镜对107例不明原因消化道出血患者进行检查,其中男61例,女46例,平均年龄(51.6±18.9)岁。其中36例患者依据胶囊内镜所观察到的结果,选择经口或经肛行双气囊小肠镜检查和(或)手术探查。结果:107例患者中106例(99.1%)完成胶囊内镜检查,75例(70.8%)胶囊内镜通过回盲瓣。107例中病变检出96例(89.7%)、确诊70例(65.4%)。36例中再经双气囊小肠镜检查和(或)手术后证实胶囊内镜诊断者为26例(72.2%)。2例(1.9%)发生胶囊滞留。结论:胶囊内镜对不明原因消化道出血具有较高的诊断价值,可作为病因诊断的首选筛查手段,与双气囊小肠镜联合应用可大大提高疾病的确诊率。     

Fields of applications,diagnostic yields and findings of OMOM capsule endoscopy in 2400 Chinese patients

AIM:To retrospectively analyze the fields of application,diagnostic yields and findings of OMOM capsule endoscopy in Chinese patients.METHODS:A database including 2400 Chinese patients who received OMOM capsule endoscopy in 27 endoscopy centers in China was retrieved from the Jianshan Science and Technology Ltd.OMOM capsule endoscopy database.The patient's age,gender,fields of application,the potentially relevant findings,pyloric transit time(PTT),small bowel transit time(SBTT),and complete small-bowel exam...     

Wireless capsule endoscopy: Perspectives beyond gastrointestinal bleeding

Wireless capsule endoscopy (CE) is a technology developed for the endoscopic exploration of the small bowel. The first capsule model was approved by the Food and Drug Administration in 2001, and its first and essential indication was occult gastrointestinal (GI) bleeding. Over subsequent years, this technology has been refined to provide superior resolution, increased battery life, and capabilities to view different parts of the GI tract. Indeed, cases for which CE proved useful have increased significantly over the last few years, with new indications for the small bowel and technical improvements that have expanded its use to other parts of the GI tract, including the esophagus and colon. The main challenges in the development of CE are new devices with the ability to provide therapy, air inflation for a better vision of the small bowel, biopsy sampling systems attached to the capsule and the possibility to guide and move the capsule with an external motion control. In this article we review the current and new indications of CE, and the evolving technological changes shaping this technology, which has a promising potential in the coming future of gastroenterology.     

Capsule endoscopy： Current status in obscure gastrointestinal bleeding

Capsule endoscopy (CE) is a safe, non invasive diagnostic modality for the evaluation of small bowel lesions. Obscure gastrointestinal bleeding (OGIB) is one of the most important indications of capsule endoscopy. Capsule endoscopy has a very high diagnostic yield especially if the bleeding is ongoing. This technique appears to be superior to other techniques for the detection of suspected lesions and the source of bleeding. Capsule endoscopy has been shown to change the outcome in patients with obscure gastrointestinal (GI) bleed.     

Five years' experience with capsule endoscopy in a single Center

Capsule endoscopy (CE) is a novel technology that facilitates highly effective and noninvasive imaging of the small bowel. Although its efficacy in the evaluation of obscure gastrointestinal bleeding (OGIB) has been proven in several trials, data on uses of CE in different small bowel diseases are rapidly accumulating in the literature, and it has been found to be superior to alternative diagnostic tools in a range of such diseases.Based on literature evidence, CE is recommended as a first-line investigation for OGIB after negative bidirectional endoscopy. CE has gained an important role in the diagnosis and follow-up of Crohn's disease and celiac disease and in the surveillance of small bowel tumors and polyps in selected patients. Capsule retention is the major complication, with a frequency of 1%-2%. The purpose of this review was to discuss the procedure, indications, contraindications and adverse effects associated with CE. We also review and share our five-year experience with CE in various small bowel diseases. The recently developed balloon-assisted enteroscopies have both diagnostic and therapeutic capability. At the present time, CE and balloon-assisted enteroscopies are complementary techniques in the diagnosis and management of small bowel diseases.     

不同年龄层不明原因消化道出血患者胶囊内镜诊断结果分析

目的 对不明原因消化道出血患者的胶囊内镜(CE)检查结果进行分析,总结不同年龄层患者的病变特点.方法 收集我院2006年12月～2010年2月间符合纳入标准的患者163例,采集患者信息并分析病变特点.结果 163例患者中,老年组患者检出率高于青年组和中年组,差异有统计学意义(P＜0.01);不同年龄组患者检出病变类型分布比较,差异有统计学意义(P＜0.05),青年组以肿物为主;中年组以溃疡、血管畸形为主;老年组以血管畸形为主.结论 各年龄组间的检出率和诊断率比较差异有统计学意义(P＜0.05),提示CE检查对老年组患者的不明原因消化道出血有更好的检出率.     

Correlation between predicted and actual consequences of capsule endoscopy on patient management

BACKGROUND: Capsule endoscopy (CE) is a relatively new diagnostic modality in the evaluation of patients with suspected small bowel pathology. It is unclear to what extent physicians are able to predict the clinical consequences of CE on patient management. METHODS: In this prospective study, 180 consecutive CE examinations were analysed. Prior to CE, referring physicians were asked to indicate the consequences of CE according to potential different CE outcomes. The influence of CE on patient management was determined with at least 1 year follow-up. Management consequences were defined as major (surgical or endoscopic intervention, or medical therapy) or minor (nonspecific therapy, including iron supplementation, or no further diagnostic tests). RESULTS: CE led to major management consequences in 32% of cases. Of patients with obscure gastrointestinal bleeding and normal CE findings, 91% were independent of blood transfusions and experienced no further bleeding episodes during a mean follow-up of 33 months. In 78% of 118 cases that were evaluated, the actual consequences of CE matched the consequences predicted by the referring physicians. CONCLUSION: CE had a major impact on patient management in about one third of investigations. In the majority of cases, physicians adequately predicted the clinical consequences of CE.